Trials / Unknown
UnknownNCT04718051
S.P.PRO LIVER POWDER is Used to Improve Liver and Metabolic Indexes in People With Non-alcoholic Fatty Liver Disease
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Taipei Medical University WanFang Hospital · Academic / Other
- Sex
- All
- Age
- 35 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
With the Westernization of the diet and insufficient exercise, Taiwan's population of obesity, diabetes, and hyperlipidemia has increased in recent years, and the prevalence of the non-alcoholic fatty liver disease has gradually increased. Although weight loss, dietary adjustments, and certain drug treatments can delay the deterioration of the disease; however, weight loss and dietary adjustment are not easy.
Detailed description
With the Westernization of the diet and insufficient exercise, Taiwan's population of obesity, diabetes, and hyperlipidemia has increased in recent years, and the prevalence of the non-alcoholic fatty liver disease has gradually increased. Although weight loss, dietary adjustments, and certain drug treatments can delay the deterioration of the disease; however, weight loss and dietary adjustment are not easy. Moreover, drugs also have side effects, and there is currently no convenient and effective treatment for people who have non-alcoholic fatty liver disease. The purpose of this trial is that investigating and evaluating the effects on fatty liver, liver fiber, and metabolic indexes after subjects using Shen Pu Yang Gan Wan.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Shen Pu Yang Gan Wan | Shen Pu Yang Gan Wan is Traditional Chinese Medicine; in addition, it has a high dose. |
| DRUG | Placebo | Shen Pu Yang Gan Wan is Traditional Chinese Medicine; however, it has a very low dose. |
Timeline
- Start date
- 2021-01-13
- Primary completion
- 2021-12-31
- Completion
- 2021-12-31
- First posted
- 2021-01-22
- Last updated
- 2021-01-22
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT04718051. Inclusion in this directory is not an endorsement.